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Abstract.  Ryanodine receptors (RyRs) are intracellular 
calcium release channels that participate in controlling 
cytosolic calcium levels.  At variance with the probably 
ubiquitous inositol 1,4,5-trisphosphate-operated cal- 
cium channels (1,4,5-trisphosphate receptors), RyRs 
have been mainly regarded as the calcium release 
channels controlling skeletal and cardiac muscle con- 
traction. Increasing evidence has recently suggested 
that RyRs may be more widely expressed, but this has 
never been extensively examined. Therefore, we 
cloned three cDNAs corresponding to murine RyR 
homologues to carry a comprehensive analysis of their 
expression in murine tissues. Here, we report that the 
three genes are expressed in almost all tissues ana- 
lyzed, where tissue-specific patterns of expression 
were observed. In the uterus and vas deferens, expres- 
sion of RyR3 was localized to the smooth muscle 
component of these organs. In the testis, expression 
of RyR1 and RyR3 was detected in germ cells. RyR 
mRNAs were also detected in in vitro-cultured cell 
lines. RyR1, RyR2, and RyR3 mRNA were detected in 
the cerebrum and in the cerebellum. In situ analysis 
revealed a cell type-specific pattern of expression in 
the different regions of the central nervous system. 
The differential expression of the three ryanodine re- 
ceptor genes in the central nervous system was also 
confirmed using specific  antibodies against the respec- 
tive proteins. This widespread pattern of expression 
suggests that RyRs may participate in the regulation of 
intraceUular  calcium homeostasis in a range of cells 
wider than previously recognized. 
I 
NCREASES in the cytosolic calcium concentration [Ca2+]i 
are  observed  after extracellular  stimulation  of many 
cells, where they contribute to the integrated intracellu- 
lar signaling pathways that control cellular functions (Ber- 
ridge,  1993). [Ca2+]~ can be increased either by the opening 
of  calcium channels on the plasmamembrane, to generate an 
influx of Ca  2÷ from extracellular fluids, or by the activation 
of Ca  2÷ release channels located on intraceUular membra- 
nous compartments of  the ER that are specialized for storing 
Ca  2÷ (Pozzan et al.,  1994). Two different families of cal- 
cium release channels located on these intracellular  stores 
are known: one is sensitive to inositol  1,4,5-trisphosphate 
(InsP3)' and is referred to as the InsP3 receptor  (Ferris and 
Snyder, 1992; Mikoshiba,  1993); the other is identified by 
its ability to bind the plant alkaloid ryanodine (Ry)' hence 
its name,  Ry receptor  (RyR) (McPherson  and  Campbell, 
1993b; Sorrentino and Volpe, 1993). 
Ca  2÷ release through InsP3 receptors  has been described 
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in almost all cell types, and it is viewed as an ubiquitous 
mechanism to regulate intracellular  calcium release. InsP3 
receptors are activated to release calcium by InsP3 binding. 
This way, production of InsP3 by phospholipase C links cal- 
cium release from InsP3 receptors to the stimulation of the 
receptors  for various growth factors and hormones on the 
cell surface (Berridge, 1993). Three genes coding for RyRs 
have so far been identified. These include the RYR1 gene en- 
coding the skeletal muscle isoform (Takeshima et al., 1989; 
Zorzato et al., 1990), as well as the RYR2 gene expressing 
the isoform present in the heart (Nakai et al., 1990; Otsu et 
al.,  1990). More  recently, a  third  RyR (RyR3) has been 
cloned (Giannini et al., 1992; Hakamata et al., 1992). The 
RyRs/calcium channels,  although  distinct  from the InsP3 
receptors, share with them several structural features. How- 
ever,  despite  these  structural  analogies,  InsP3 is  not  an 
effective agonist of calcium  release through  RyRs. Cyclic 
adenosine  diphosphoribose,  a  metabolite  of nicotinamide 
adenine dinucleotide,  has been recently  shown to be able 
to stimulate Ca  2+ release through  RyRs, independently  of 
InsP3 generation  (Galione,  1993; Lee et  al.,  1993). In- 
terestingly, cyclic adenosine diphosphoribose has been de- 
tected in many and possibly all cells (Howard et al., 1993). 
Less is known about the expression pattern of RyRs. Along 
with skeletal and cardiac muscle, the brain is the only other 
©  The Rockefeller University Press, 0021-9525/95/03/893/12  $2.00 
The Journal of Cell Biology, Volume 128, Number 5, March 1995 893-904  893 tissue where the presence of RyR has been well documented 
(McPherson and Campbell,  1993a). A thorough biochemi- 
cal characterization has shown that the cardiac RyR2 is the 
major isoform present in several regions of the central ner- 
vous system (McPherson and Campbell, 1993a; Sharp et al., 
1993), while RyR1 was shown to be exclusively expressed 
in cerebellum Purkinje cells (Kuwajiima et al., 1993). RyR3 
mRNA has been found by Northern blot in a few restricted 
areas of the brain, including the corpus striatus, the thala- 
mus, and the hippocampus, but not the cerebellum (Haka- 
mata  et  al.,  1992).  Expression  of RyR2  has  also  been 
detected  in  vascular  and  endocardial  endothelium  using 
Northern blot analysis and antibodies against RyR (Lesh et 
al.,  1993), as well as in the brain and stomach by Northern 
blot analysis (Nakai et al., 1990; Otsu et al., 1990). During 
the last years, the existence of RyRs in several noncontractile 
cells such as neurons, chromaftin cells, and secretory cells 
has been documented (Kasai et al.,  1993; Kasai and Peter- 
sen, 1994; Takasawa et al., 1993; Thorn et al., 1993). RyRs 
have also been studied in sea urchin eggs (Galione et al., 
1993;  Lee et al.,  1993; McPherson et al.,  1992). Most of 
these data are, however, mainly based on pharmacological 
evidence, and with few exceptions, identification of RyRs in 
different tissues and cell types is largely incomplete. Fur- 
thermore, from the existing data, it is not possible to deter- 
mine which of the three known RyR is present in a given tis- 
sue or cell, nor whether more than one isoform is present. 
In addition, other intracellular RyR/calcium channels that 
are  not well characterized have been described,  differing 
in their biochemical and/or pharmacological properties from 
cardiac  and  skeletal  muscle  RyRs,  making  the  issue  of 
RyRs identification in nonmuscle cells even more intricate 
(Schmid et al.,  1990). 
During our initial studies on the expression pattern of the 
type 3  RyR,  we realized that it was  likely that RyR1 and 
RyR2 could also be expressed in tissues that do not contain 
an evident muscle or neuronal component, as well as in sev- 
eral cell lines. This prompted us to isolate cDNA clones for 
the murine RyRs and to investigate the expression in murine 
tissues of these genes by RNase protection assay, because of 
its high sensitivity and stringency, and by in situ hybridiza- 
tion to identify the cells expressing these receptors within a 
given tissue. Expression of  the three RyR proteins in the cen- 
tral nervous system (CNS) was also investigated by Western 
blot,  with antisera raised against recombinant protein se- 
quences specific for the three different RyR isoforms. 
Materials and Methods 
Cloning of  Murine cDNAs for RyRI, RyR2, and RyR3 
Standard protocols were used to isolate murine eDNA for RyR1, RyR2, and 
RyR3 by screening a mouse brain eDNA library with a human RyR3 com- 
plementary DNA under low stringency conditions (Mattei et al., 1994; Sor- 
rentino et al.,  1993).  Three plasmids, pMB9, pMB3, and pMBIII7, were 
isolated, and the three inserts were identified by nucleotide sequence analy- 
sis as partial eDNA corresponding to RyR1, RyR2, and RyR3, respectively. 
The sequence data used in this study are available  from EMBL/GenBank/ 
DDBJ under accession numbers X83932-X83934. 
RNase Protection Analysis 
Total  RNA  from  adult  mouse tissues  was  purified  by  the  guanidine 
isothiocyanate/CsCl  method  as  previously  described  (Morrone  et  al., 
1989).  mRNA levels have been determined by RNase protection because 
of the high sensitivity and specificity of this technique. 
The  EcoRI-Styl  fragment  isolated  from  pMB9  was  subcloned  into 
pBSSK plasmid (Stratagene, La Jolla, CA). This construct was linearized 
at an internal Avail site, located 350 bp upstream the Styl site, to generate 
an antisense RyR1 probe. An internal 1,661-bp EcoRI fragment from pMB3, 
corresponding to a partial mouse RyR2 eDNA, was subcloned into pBSKS. 
The construct was linearized at the internal Styl site located 307 bp up- 
stream to the 3' end of the subclone. The RyR3 MTul I mouse eDNA sub- 
clone was linearized with BgllI to produce a RyR3-specific, 410-bp cRNA 
probe.  RyR1,  RyR2,  and  RyR3  antisense cRNA probes were obtained 
by transcription of the  above-mentioned constructs  in  the  presence of 
[c~-3zP]UTP (800  Ci/mmol;  Amersham Corp.,  Arlington  Heights,  1L) 
with a polymerase transcription kit (T3/T7;  Stratagene), according to the 
manufacturers instructions. After purification on an 8 % sequencing gel, 
2.5  ×  105 cpm of the three cRNA probes were hybridized to total RNA 
from indicated tissues in 30 #1 of a buffer containing 40 mM Pipes pH 6.4, 
1 mM EDTA, 0.4 M NaC1, and 80% formamide overnight at 55°C. After- 
wards,  the hybrids were treated with RNase  A  (40  #g/ml;  Sigma Im- 
munochemicals,  St.  Louis,  MO)  and  RNase  T1  (2  t~g/rnl;  Boehringer 
Mannheim Biochemicals, Indianapolis, IN) for 1 h at 33°C. Samples were 
further treated with proteinase K (50 ~,g; Boehringer Mannheim) in the 
presence of 0.4% SOS at 37°C for 30 rain, phenol-chloroform extracted, 
ethanol precipitated, and analyzed on an 8% sequencing gel (Marziali et 
al., 1993).  10 t~g of total heart RNA and 5 trg of  total skeletal muscle (thigh 
or diaphragm) RNA were analyzed with RyR2 and RyRI  cRNA probes 
respectively. 50 tzg of transfer RNA was hybridized to each probe as a nega- 
tive control. Both RNase protection and in situ hybridization experiments 
have been performed with several different probes for each gene, including 
sequences corresponding to regions of divergence among the three RyRs. 
In Situ Hybridization 
Adult mouse tissues were excised and directly frozen in OCT compound on 
dry ice. Serial 10-mm cryosections were stored at -80  ° up to 2 mo. Before 
hybridization, sections were thawed in cold acetone, fixed for 15 min in 4% 
paraformaldehyde, and acetylated. After a denaturing step at 70°C in 2 x 
SSC 50% formamide, sections were dehydrated in graded ethanols. Probes 
used were derived from many portions of  the eDNA probes isolated. Single- 
strand sense and antisense cRNA probes were obtained by transcription 
with T3 or T7 RNA polymerase in the presence of ([c~-35S] CTP, >1000 
Cimmol-I; Amersham). Probes were digested to 50-100  nucleotides by 
mild alkaline hydrolysis. Hybridization was carried out as described (Doll6 
and Duboule, 1989). After washing and RNase treatment, sections were de- 
hydrated in graded ethanols containing 300 mM NIL, acetate, and were 
dipped in NBT2 emulsion (Eastman Kodak, Co., Rochester, NY) diluted 
1:1 in water. After 2-3 wk, slides were developed with D19 developer (Ko- 
dak) washed in distilled water, and fixed in AL-4 fixer (Kodak). The slides 
were counterstained with  Toluidine blue,  and coverslips were mounted 
using Eukitt (O. Kindler GmbH, Freibourg, Germany). 
Fusion Proteins and Polyclonal  Antisera 
The nucleotide sequence corresponding to the region of low homology situ- 
ated between the transmembrane domains 4 and 5 (divergent region 1 or 
D1) of the RyR1 gene was amplified using the oligonucleotides mSkS'2T 
(5'GTGGATCCCAGCCGAGCGC~GC~)  and mSk3'2T (5'CAGAAT- 
TCTTCCAGGCCTGCTCCTCC).  The same region of the RyR2 gene was 
amplified using the olgionucleotides mCaS'2T (5'GTGGATCCGAAGAGG- 
AGGGAGAGAGG)  and  mCa3'2T  (5'CCGAAT'I~CTATGAT'ITI'CTTC- 
CAGAA).  The  oligo ryr3DI-5'  (5'G'IV_d3ATCCCTCd3ATGCTGAGCGG- 
GCA) and ryr3DI-3' (5'CCGAATTCGGTCTGATAGATTTCCAC-rC)  were 
used to amplify the D1 region of the RyR3 gene. The fragments were di- 
gested with EcoRI and BamHI  and subcloned in the pGEX2T plasmid 
(Pharmacia, Freiburg, FRG) digested with the same enzymes. The resulting 
plasmids were transformed in the JM101 strain of Escherichia coll. Recom- 
binant proteins were induced with isopropyl-~-o-thiogalacto-pyranoside  as 
described (Smith and Johnson, 1988). Cells were washed in PBS containing 
1% Triton X-100 and 100 mM EDTA (PBSTE) and sonicated. The bacterial 
lysate was cleared by centrifugation. Glutathione agarose beads (Pharma- 
cia) were then added and incubated for 10 min at 4 C. After several washes 
with PBS, the recombinant proteins were eluted with 50 mM Tris, pH 8, 
containing 10 mM reduced glutathione. Polyclonal rabbit antisera were de- 
veloped against these GST fusion proteins according to standard protocols 
(Ausubel et al.,  1993). 
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Western Blot 
Bovine brains from a  local  slaughter house were dissected to  separate 
specific areas,  microsomal membranes were prepared by homogenization 
with a Dounce homogenizer of 1 g of  tissue in 5 ml of a solution containing 
320 mM sucrose, 0.1 mM PMSF, and 5 mM Hepes-NaOH pH 7.4 (buffer 
A).  The  homogenate  was  centrifuged at  10,000  g  for  5  rain  at  4"C. 
Microsomal membranes were obtained  as  a  pellet by  centrifugation at 
100,000  g  for 60 rain at 4°C. Microsomes were resuspended in buffer A 
and stored at -80"C. Protein concentration of  the microsomal fraction was 
quantified using a protein assay kit (Bio Rad Laboratories, Hercules, CA). 
For Western blot analysis, 100 tzg of microsomal proteins were separated 
on 5 % SDS-PAGE and transferred to nitrocellulose membranes (Schleicher 
&  Schuell, Inc., Keene, NH) following standard procedures. Membranes 
were blocked for 3 h in blocking buffer containing 150 mM NaCI, and 50 
mM Tris-HCl, pH 7.4,  with 0.2% Tween 20 and 5% dry milk) and then 
incubated overnight with a  1 to 3,000 dilution of the immune sera in the 
same buffer.  Specific antigen detection was performed using the Amplified 
Alkaline Phosphatase Immunoblot reagents from Bio Rad. For competition 
experiments, 6/~1 of each undiluted antiserum were preincubated with 100 
/~g of recombinant protein in 500 tzl of blocking buffer.  After 4 h, the ad- 
sorbed antisera were diluted and blotted as described above. 
Cell Cultures 
Cells were passaged in DME medium containing 10%  fetal calf serum. 
Cells, unless otherwise indicated, were typically grown for 2 d before being 
treated with TGFB at 3 ng/ml. Cells, either treated with TGFB (+) or un- 
treated (-) were then harvested after 24 h and processed for RNA prepara- 
tion. RD cells, a human rhabdomiosarcoma cell line, were kindly provided 
by Dr.  M.  Bouche (University of Rome, Rome, Italy) (Aguarmo et al., 
1990).  HCll ceils, a murine mammary epithelial cell line, were provided 
by N. Hynes (Friedrich Miescher Institute, Basel, Switzerland) (Hynes et 
al.,  1990).  HACAT  cells,  a  human keratinocyte cell  line,  were kindly 
provided by N.  Fusenig (D.K.EZ., Heidelberg, Germany). Hep 3B cells 
derived from a human hepatoma, and A459 cells derived from a human lung 
carcinoma, have been previously described (Morrone et al., 1989).  Friend 
erythroleukemia cells are murine proerythrocytes that can be induced to 
differentiate to the proerythroblast stage (Coccia et al., 1992).  Differentia- 
tion of C2C12 cells was achieved by culturing ceils in low serum as de- 
scribed (Airey et al.,  1991). 
Results 
RyR Genes Are VC~dely  Expressed in Mouse Tissues 
Initial studies on RyR1 and RyR2 mRNA distribution have 
detected expression of the former in skeletal muscle (Take- 
shima et al.,  1989;  Zorzato et al.,  1990),  and of the latter 
in the heart, brain, and possibly stomach (Nakai et al., 1990; 
Otsu et al.,  1990).  On the contrary, RyR3 was found to be 
widely expressed in mink tissues and in some rabbit tissues 
(Giannini et al., 1992; Hakamata et al., 1992).  To study the 
expression of RyRs in mouse tissues,  partial  cDNAs  for 
RyR1, RyR2, and RyR3 were isolated from a mouse brain 
cDNA  library  as  described  in  Materials  and  Methods. 
Specific cRNA probes  derived from these plasmids were 
subsequently used for RNase protection experiments on total 
RNA prepared from murine tissues (Fig.  1). 
As expected, the highest levels of RyR1 expression were 
detected in skeletal muscle (note that for RNase protection 
of RyR1, only 5 mg of total RNA from diaphragm and thigh 
were analyzed, while 50/~g of total RNA from other tissues 
were used). Actually, by comparing the expression levels of 
RyR1  in different muscles,  we observed  higher levels of 
RyR1  mRNA in diaphragm than in thigh muscles.  RyR3 
mRNA was also expressed in skeletal muscle, although at 
lower levels  than RyR1,  as previously described in mink 
(Giannini et al.,  1992).  Again, similarly to what observed 
for  RyR1  mRNA,  the  levels  of RyR3  mRNA  in the  di- 
aphragm were higher than those observed in thigh muscles. 
No signal was detected when RyR2 eDNA was used to probe 
RNA extracted from skeletal muscle. 
RyR2 was expressed at the highest level in the heart, as 
previously reported (for RNase protection of RyR2, only 10 
/zg of  RNA from the heart was analyzed, while 50 gg of  RNA 
from other tissues were used). RyR3 mRNA was also de- 
tected in the heart (Fig. 1), but at variance with RyR2, which 
is expressed in myocytes, RyR3 is preferentially expressed 
in the Purkinje cells of the cardiac conduction system (Gorza 
et al., 1995). In agreement with the results obtained in mink 
tissues the RyR3 gene appeared to be widely transcribed in 
mouse tissues, being detectable in the cerebrum,  cerebel- 
lum, lung, esophagus,  spleen,  gut,  kidney, stomach, sub- 
maxillary gland, thymus, testis, adrenal gland, and ovary. 50 
~g of total RNA from each tissue was used in RyR3 RNase 
protection experiments. 
To our surprise,  although not completely unexpectedly, 
both RyR1 and RyR2 transcripts were detected in a large ar- 
ray of tissues. Both RyR1 and RyR2 mRNAs were found, al- 
though expressed at different levels, in mouse cerebrum and 
cerebellum. Significantly  higher levels of RyR1 mRNA were 
also observed in the esophagus and testis compared to other 
organs; however,  lower amounts were found in the spleen, 
gut, kidney, stomach, submaxillary gland, thymus, adrenal 
gland, and ovary. RyR2 mRNA was detected in esophagus, 
gut,  kidney, stomach,  thymus,  testis,  adrenal gland,  and 
ovary, and at higher levels in the lung. No hybridization of 
any of the three probes was visible against tRNA, which was 
used as a  negative control.  In contrast with results  from 
[3a]Ry  binding, we did not observe large amount of RyRs 
mRNAs  in  the  liver  (Shoshan-Barmatz  et  al.,  1991). 
Whether this suggests the presence of other RyRs different 
from the three genes we have studied, or the presence of a 
Ry-binding protein in the liver that is different from RyRs, 
is not clear at the moment. 
Figure I. RNase  protection analysis of RyRI, RyR2, and RyR3 ex- 
pression in mouse tissue. Hybridization was carried out as de- 
scribed in Materials and Methods. 50/~g of total RNA were used 
for analysis with the exception of skeletal muscle (thigh and di- 
aphragm) and heart, where 5 and 10 #g of total RNA were hybrid- 
ized to RyR1 and RyR2 probes, respectively. 50/~g of tRNA was 
used as a negative control for each probe. 
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Pattern of the Three RyR Genes in the Mouse Brain 
RyR2 has been shown to be the major RyR protein present 
in  brain  (McPherson  and  Campbell,  1993a).  However, 
RNase protection experiments indicated that also RyR1 and 
RyR3 mRNAs were expressed in both mouse cerebrum and 
cerebellum (Fig.  1). To systematically study the pattern of 
distribution of the three RyR isoforms in the mouse brain, 
RyR1, RyR2, and RyR3 cRNA probes, prepared as described 
in  the  methods  section,  were  hybridized to  sagittal  and 
coronal brain cryosections. RyR1 mRNA expression was de- 
tected as a strong positive signal in Purkinje cells (Figs.  2 
A, 3 C1, and 4 D1 ), which appeared to be the only RyR1- 
positive cell population in the cerebellum, in agreement with 
a previous report (Kuwajiima et al., 1992).  However, RyR1 
probe also yielded a specific signal in the dentate gyrus of 
the hippocampus and in the less strongly stained CA3 and 
CA1 cells of the Ammon's horn (Figs. 2 A, 3 B1, and 4, B1 
and C1 ). In more anterior regions, RyRl-specific expression 
was observed on caudate/putamen nuclei (Figs. 2 A and 4 
A/), on the olfactory tubercle (Figs. 2 A and 3), and on the 
olfactory bulb (Fig. 2 A, where it is specifically expressed 
in the mitral cell layer (Fig. 3 A/). Expression of RyR1 was 
also observed in the cortex (Figs.  2 A and 4  A/).  As ex- 
pected, a broader pattern of  expression was revealed with the 
RyR2 cRNA probe. In the cerebellum, RyR2-specific grains 
were mainly localized to the granular cell layer (Figs.  2 C, 
3 C2, and 4 D2). In the cerebrum, intense staining was also 
revealed in the hippocampus (Figs. 2 C, 3 B2, and 4, B2 and 
C2), both  in the dentate gyrus and in the Ammon's horn 
(CA3-CAI). However, RyR2 expression was also detected at 
the level of the medial habitual nuclei, in the amygdala (Fig. 
4B2), and in more anterior regions, in the cortex (Figs 2 and 
3) and in the granular cell layer of the olfactory bulb (Figs. 
2 C and 4, A2 and B2). RyR3 mRNA expression was evident 
in several structures in the mouse brain.  The RyR3 probe 
also appeared to preferentially stain the granular cell layer 
in the cerebellum, although the signal was much weaker than 
that produced by the RyR2 probe (Figs.  2 E, 3  C3, and 4 
D3).  RyR3  specific  signal  was  also detected in the hip- 
pocampus, but with a pattern different from those of RyR1 
and RyR2. RyR3 probe, in fact, labeled the dentate gyrus 
less strongly than the Ammon's horn (Figs.  2 E, 3 D3, and 
4 B3 and C3). In this latter structure, RyR3 was found to be 
more enriched in the CA1 region compared to CA3 (Figs. 2, 
3 B3,  and  4,  B3  and  C3),  with a  distribution similar to 
InsP3 receptors  (Sharp et al.,  1993).  A  sparse signal was 
also  detected  with the  RyR3  probe  in  the  thalamic  and 
hypothalamic regions,  as well as  in the candate/putamen 
nuclei (Figs.  2 E  and 4 B3).  In the olfactory bulb, RyR3 
mRNA was detected in the mitral cell layer and in the granu- 
lar cell layer, overlapping both RyR1 and RyR2 expression 
(Figs. 2 E and 3 A3). Strong labeling was also revealed in 
the olfactory tubercle.(Fig. 2 E). Finally, the RyR3-specific 
signal was detected in the lateral septum (Fig. 4 A3) and, in 
more posterior sections, in a region were the dorsalis raphae 
nuclei are located (Fig. 4 D3).  RyRI-, RyR2-, and RyR3- 
labeled sense probes gave no signal on parallel sagittal (Fig. 
2, B, D, and F) or coronal (not shown) sections. 
Figure 2.  Pattern of expression of RyR1, RyR2, 
and RyR3 genes in adult mouse brain. Dark-field 
micrographs of serial sagittal cryosections  of adult 
mouse brain in situ hybridized to antisense (.4, C, 
and E) and sense (B, D, and F) cRNA probes for 
RyR1 (A and B),  RyR2 (C and D),  and RyR3 
(E and F). OB, olfactory bulb; CA, Ammon's  horn 
of the hippocampus; DG, dentate gyrns; Ctx, cor- 
tex; Tu, olfactory tubercle; Th, thalamus; CP, cau- 
date putamen; Cb, cerebellum. Bar, 1.2 mm. 
The Journal  of Cell Biology,  Volume 128. 1995  896 Figure 3. Dark-field micrographs of sagittal brain cryosections showing details of RyR1 (A/, B/, and C1 ), RyR2 (A2,172, and C2), and 
RyR3 (,43, B3, C3) patterns of expression in the olfactory bulb (A-A3), in the hippocampus (B1-B3), and in the cerebellum (C1-C3). 
Toluidine staining of parallel sections is shown in A4, 114, and C4. CAI-CA3, fields of Ammon's horn of the hippocarnpus; DG, dentate 
gyrus; ML, molecular layer; GL, granular layer; P, Purkinje cells; EPL, external plexiform layer; MCL, mitral cell layer; IGL, internal 
granular layer. Bar in A4, 240 ~m; B4, 180 #m; C4,  180 #m. 
Differential Expression of the Three RyR Proteins in 
Specific Regions of the Central Nervous System 
The distribution of the three RyRs in the central nervous sys- 
tem was further investigated using specific antisera devel- 
oped against the three different  RyR isoforms. These antisera 
identify three distinct proteins of '~500 kD in molecular 
mass which display a clear tissue specificity of expression. 
The anti RyR1 antiserum reacted specifically with a high mo- 
lecular weight protein that is present in the sarcoplasmic 
reticulum of skeletal muscle, while the anti-RyP,2  and the 
anti-RyR3 antisera recognized similar but distinct bands in 
cardiac muscle and the hippocampus, respectively (Fig. 5 A, 
lanes labeled with a minus). The specificity of  these three an- 
tisera was further demonstrated by competition experiments 
using the recombinant proteins initially used to immunize 
the rabbits. As shown in Fig. 5 A, competition of the antise- 
rum against the RyR1 with the recombinant RyR1 protein 
prevented the detection of the band expressed in skeletal 
muscle and a comparable situation was observed when an- 
tisera against RyR2 and RyR3 were competed by the respec- 
tive proteins (Fig. 5 A, lanes labeled with a plus).  Heterolo- 
gous  proteins  did not compete the antisera (not shown). 
Interestingly, the three proteins recognized by these antibod- 
ies present a  slight difference in their apparent molecular 
weight. It has been reported that the RyR2 proteins have a 
faster mobility with respect to RyRI. Here, we show that the 
Giannini et al. Tissue Expression of Ryanodine Receptors  897 Figure 4.  Dark-field micrographs of serial coronal cryosections of adult mouse brain in situ hybridized to RyRI (A/, B1, C1, and D1 ), 
RyR2 (.42, B2, C2, and 2D), and RyR3 (A3, B3, C3, and D3) antisense cRNA probes. CA1-CA3, fields of Ammon's horn of the hip- 
Ix)campus; DG, dentate gyrus; Ctx, cortex; Tu, olfactory tubercle; LS, lateral septum; Th, thalamus; A, amygdala; CP, caudate putamen; 
MH, medial habenula; Cb, cerebellum. Bar, 1.2 ram. 
RyR3 protein runs slightly ahead of the RyR2 (Fig.  5 A). 
These relative differences in the apparent molecular weight 
of  the three RyRs proteins are in agreement with the expected 
length of these proteins as deduced by the nucleotide se- 
quences of the respective cDNAs (Coronado et al.,  1994). 
These antibodies were then used to analyze the presence of 
RyRs in microsomal fractions prepared from specific areas 
of the CNS regions (Fig. 5 b). In agreement with in situ hy- 
bridization data, RyR1 protein was predominantly localized 
in microsomal fractions prepared from the cerebellum, but 
also from the hippocampus and s[riatum. No clear signal was 
detectable with the antiserum against RyR1 in other regions 
of the  CNS,  at  least under  our  experimental conditions. 
RyR2 isoform was present in microsomal proteins prepared 
from all regions examined. RyR3 was detected, at the highest 
levels,  in fractions prepared from hippocampus, striatum, 
and cerebral cortex; the least of expression was observed in 
the brain stem. Interestingly, with respect to other regions 
of CNS, RyR3 protein appears to be even more abundant in 
the cerebral cortex than expected, based on in situ hybridiza- 
tion results.  Despite RyR3, mRNA is detected in total RNA 
prepared from skeletal and cardiac muscles; expression of 
RyR3 protein  was  not detected in preparations  of micro- 
somes from these tissues, even when higher amounts of pro- 
tein were loaded on gels (not shown). This is very likely to 
result from the low levels of RyR3 protein present in these 
two tissues, especially skeletal muscle, compared with its ex- 
pression  in  brain.  Preliminary  results  from  large  scale 
purification experiments do, however, demonstrate the pres- 
ence of the RyR3 protein, although at low levels, in these tis- 
sues (Conti, A., unpublished observations). 
In Situ Hybridization on Mouse Peripheral I~ssues 
RNase protection experiments have shown that a message 
specific for RyR1, RyR2, and RyR3 can be detected in sev- 
eral mouse peripheral tissues, although at much lower levels 
than in brain or muscle. (Fig.  1).  On these bases, some of 
these tissues were chosen for in situ hybridization experi- 
ments. Probes specific for the three RyRs were in situ hybrid- 
ized to serial transversal sections of the organs contained in 
the mediastinal cavity (including heart, lungs, thymus, and 
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tibodies against RhyRl, RyR2, and RyR3 recognize a single band 
in microsomes prepared  from  skeletal  muscle,  heart,  and  hip- 
pocampus, respectively. The minus (-) refers to antibodies not 
preincubated with recombinant protein; the plus (+) refers to ex- 
periments where the antibodies were preincubated with the recom- 
binant protein used as antigen in the respective immunization pro- 
tocol. (B) Localization of the isoforms of RyR in different areas of 
the CNS using antibodies specific for the different isoforms. Skele- 
tai muscle microsomes were prepared from the posterior legs of a 
mouse. Cardiac microsomes were prepared from the entire heart, 
cleaned from large vessels. 5/zg of  microsomal proteins from skele- 
tal muscle and from heart were loaded on gel. 100 g of  microsomal 
proteins were loaded for all other samples. 
esophagus).  In these sections,  RyR1  mRNA  was detected 
only in the esophagus (Fig. 6 A). In different sections (not 
shown),  the labeling corresponded to both the  inner and 
outer layers of striated muscle fibers; the signal could be fol- 
lowed to the entrance in the stomach, and it abruptly disap- 
peared as soon as the esophageal striated muscle was sub- 
stituted by the smooth muscles of the stomach. As expected, 
the RyR2 probe gave a strong signal over the whole heart (not 
shown). In addition, specific labeling was observed in pul- 
monary vessels (Fig. 6 B).  This is consistent with reports 
describing "myocardial extrusions or sleeves" over pulmo- 
nary veins in rodents, which express cardiac muscle specific 
protein isoforms in  line  with the embryological origin of 
these veins from cardiac tissue (Lyons et al.,  1990). 
Both RyRI and RyR3 mRNAs are transcribed in the spleen 
(Fig. 1). RyR3 expression was thus investigated by in situ hy- 
bridization. In cryosections of the spleen, RyR3 cRNA an- 
tisense probe clearly showed a particular pattern ofpositivity 
(Fig.  6  F).  Grains were reproducibly observed in defined 
areas that were not superimposable to either red or white 
pulp, but rather appeared, at a higher magnification, to be 
distributed in the periphery of spleen sinusoids (not shown). 
No signal was detected using the sense control probe (Fig. 
6 E). An RyR3-specific signal was clearly observed only in 
the peripheral region of the uterine muscle wall (Fig. 6 H). 
A  similar pattern was observed in the vas deferens, where 
RyR3 transcripts were detected over the entire muscular tu- 
Figure 6. Low power dark-field micrographs of mouse thoracic or- 
gans (.4 and B) spleen (E and F), uterus (G and H), and vas defe- 
rens (C and D) cryosections. Sections were in situ hybridized to 
RyRI (A), RyR2 (B), and RyR3 (D, E  and H) cRNA antisense 
probes, as well as to control RyR3 sense cRNA probes (C, E, and 
G). E, esophagus; PV, pulmonary vessels. Bars in A and B, 1 mm; 
C and D, 0.1 mm; F,, 0.45 ram; H, 0.3 mm. 
nic (Fig 6 D). Again, no signal was detected using the sense 
control probe (Fig. 6, C and G). No specific signals (com- 
pared with pictures obtained with sense control probes) were 
observed when parallel sections were hybridized to RyRI 
and RyR2 cRNA probes (not shown). 
Several other tissues, such as the lung, stomach, thymus, 
submaxillary, and adrenal glands, were found to express at 
least one of the three RyR genes by RNase protection (Fig. 
1). Unfortunately, despite repeated attempts, when those tis- 
sues were analyzed by in situ hybridization, no clear pattern 
was produced by antisense versus sense probes, probably be- 
cause of the very high background observed with the sense 
control probes (not shown). 
RyR1 and RyR3 mRNA Are Expressed in Germ Cells 
in Mouse Testis 
RNase protection experiments revealed the presence of rela- 
tively high levels of RyR1 and RyR3 mRNA in total RNA 
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periments  were  performed on transversal cryosections of 
adult mouse testis with the three cRNA probes mentioned in 
the above section. A clear positive signal was visible at the 
level of seminiferous tubules on sections hybridized with 
RyR1 (Fig. 7, A and B) and RyR3 (Fig. 7, D and E). In both 
cases, only a part of the tubules present in the section were 
stained by the probes.  Considering that germinal cells at 
different stages of differentiation are present in contiguous 
seminiferous tubules in adult mice testis, this hybridization 
pattern suggests that RyR1 and RyR3 are expressed in the 
germinal cell compartment. This was confirmed when sec- 
tions were observed at higher magnification. Silver grains 
were  particularly dense  over  germ  cells and,  more  spe- 
cifically, in areas rich in spermatocytes and spermatids (Fig. 
7, C and F). Almost no signal was present on the large sper- 
matogonia and Sertoli ceils. These results were also con- 
firmed by  RNase protection analysis performed on RNA 
extracted  from elutriated  spermatocytes,  spermatids,  and 
Sertoli cells, which demonstrated RyR1 and RyR3 expres- 
sion  in  purified  populations  of spermatocytes  and  sper- 
matids, but not in Sertoli cells (not shown). 
RyR Genes Are Transcribed in Human and Murine 
Cell Lines 
Expression of the three RyRs was studied by RNase protec- 
tion in human and murine cell lines of different lineage. 
Given our initial finding that RyR3 mRNA is inducible in 
mink MvlLu cells by TGF/~ (Giannini et al.,  1992),  RyR 
mRNAs expression was analyzed in ceils treated with the 
growth factor and compared to untreated cells (Fig. 8). RyR1 
mRNA was detected in the human HACAT and A549 cell 
lines and RyR2 mRNA was detected in Hep3B and HeLa 
cells, and their expressions were not modulated by TGFfl 
(Fig. 8 A). On the contrary, in HeLa cells, TGF2/~ treatment 
for 48 h induced expression of RyR1 but concomitantly, in- 
hibited expression of RyR3 mRNA,  compared to the un- 
treated control. Murine NIH3T3 fibroblasts expressed rela- 
tively low levels of RyR1 mRNA, both in actively growing 
or stationary conditions (not shown).  In these cells, treat- 
ment with TGF for 48 h resulted in a twofold increase of 
RyR1  expression (Fig.  8 B).  A  similar situation was ob- 
served for RyR1 in NIH3T3  cells transformed by the src 
oncogene; these cells, however,  in contrast with the non- 
transformed parent cell line, expressed RyR2 mRNA in addi- 
tion to RyR1 (Fig.  8 B).  Constitutive expression of RyR1 
mRNA was observed in the C5 epithelial cell line. In the 
mammary epithelial cell line HC11, RyR1 mRNA levels were 
influenced by TGF/3 treatment. In these cells, a constant in- 
crease in the RyR1 mRNA levels  was detected upon con- 
tinued treatment with  TGFfl  for 48  h.  In  Friend eryth- 
roleukemia cells,  basal  levels  of expression of RyR1  and 
RyR3 were detected. Expression of  both genes was not mod- 
ulated by TGF~ treatment (Fig. 8) or by induction of differ- 
entiation (not shown). 
RyR3 mRNA Expression in Myoblasts Is Linked to 
Expression of the Differentiated Phenotype 
We have found that,  along with expressing high levels of 
RyRI,  skeletal  muscle  also  expresses  low  levels  RyR3 
mRNA (Giannini et al., 1992; Fig. 1 in this paper). To verify 
whether RyR3 expression in muscle cells in constitutive or 
dependent on differentiation, we analyzed the expression of 
RyR3 in the C2C12 cells.  C2C12  cells are myoblasts that 
have the potential to differentiate to muscle cells under ap- 
propriate culture conditions (Airey et al., 1991). Expression 
of RyR1 has been shown to be induced in these cells after 
induction of differentiation (Airey et al., 1991). As shown in 
Fig.  8  C,  low  levels  of RyR3  mRNA  are  expressed  in 
undifferentiated C2C12 cells, and they increase severalfold 
after induction of differentiation. TGF~/is an inhibitor of 
differentiation  in these cells. Treatment of C2C12 with TGF~ 
reduced the expression of both RyR1 and RyR3, thus rein- 
forcing the hypothesis that upregulation of RyR3 MRNA, in 
differentiated  in  C2C12,  is  linked  to  expression  of the 
differentiated phenotype in these cells.  Expression of the 
Figure 7. RyRI  and RyR3 expres- 
sion in adult mouse testis. Serial 
transversal cryosections  of mouse 
testes were hybridized  to RyR1 (A 
andB) and RyR3  (Dand E) cRNA 
probes. Note that not all the semi- 
niferous tubules in the  sections 
are  labeled  by  RyRI or  RyR3 
probes. High power micrographs 
of the toluidine staining of the 
same sections, RyR1 (C)  and 
RyR3 (F). Bars in A and D, 0.5 
nun; B and E, 0.16 mm; C and F, 
16 #m. 
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pression in in vitro-cultured cell lines. The plus (+) indicates cul- 
tures treated with TGFB for 48 h except for HCll cells that were 
treated with TGF/3 from 12 to 48 h, as indicated in the figure, 
C2C12 cells that were cultured in differentiating  conditions for GT 
= 4 d either in the presence or the absence of TGF/g as also indi- 
cated in the figure. 
RyR3, along with RyR1, was observed also in the myogenic 
cell  line  BC3H1  (not  shown)  and  in  the  human  rhab- 
domyosarcoma cell line RD (Fig. 8 A). 
Discussion 
After skeletal and cardiac muscles, the CNS is the tissue 
where the expression of RyRs has been more extensively in- 
vestigated (McPherson and Campbell,  1993a).  Studies on 
intracellular  calcium  release  channels  in  the  CNS  have 
shown the presence,  within neurons, of both InsP3 recep- 
tors and RyRs (Sharp et al., 1993; Walton et al., 1991). This 
is consistent with the existence of two distinct intracellular 
calcium release processes in brain areas (Verma et al., 1990, 
1992).  These studies, however,  did not distinguish between 
the different RyR isoforms. Here, we report the specific pat- 
tern of expression of the three RyRs in the cerebrum and the 
cerebellum. The relative abundance of the three isoforms 
agrees with previous published results that have indicated 
that the RyR2 is the major isoform present in brain (McPher- 
son and Campbell, 1993a).  Our data indicate that RyR3 is 
more represented than RyR1, although the latter is relatively 
well expressed in Purkinje neurons of the cerebellum. By 
means of i-n Situ hybridization analysis a preferential expres- 
sion of the three RyRs has been observed in different areas 
of the CNS, such as the cerebellum, hippocampus, striatum, 
and olfactory bulb. A distinct cell type-specific expression 
was also evident within these regions. Localization differ- 
ences especially in neuronal cell populations, may reflect a 
differential usage of these channels to probably achieve a 
higher level  for functional diversification. Such a  pattern 
recalls that of the InsP3 receptors (Mikoshiba, 1993;  Sharp 
et al., 1993).  The different isoforms of InsP3 receptors have 
been shown previously to be also differentially expressed in 
the CNS  (De  Smedt et al.,  1994;  Furuichi et al.,  1990; 
Nakagawa et al., 1991; Ross et al., 1992; Sharp et al., 1993). 
Although in some cases the expression of members of these 
two types of intracellular calcium release channels may par- 
tially overlap, it is interesting to note that the overall distribu- 
tion of InsP3 receptors in the brain differs from that of RyRs 
(Sharp et al., 1993; Verma et al., 1990, 1992).  This intrigu- 
ing pattern of different types of intracellular calcium release 
channels and relative isoforms are likely to reflect the com- 
plexity of the mechanisms that are involved in the generation 
of oscillatory changes in intracellular calcium, as suggested 
by models that propose an interplay between two calcium re- 
lease  systems  for  generation of such  patterns  (Berridge, 
1993).  The predominance of one mechanism of calcium re- 
lease on the other, as well as the intracellular localization of 
these channels, are certainly important in the regulation of 
the resulting neuronal function. 
During the last few years, both pharmacological and mo- 
lecular studies have shown that cells with intracellular cal- 
cium release pools that are regulated by channels with prop- 
erties similar to those of RyRs of muscles are present, not 
only in the brain, but also in the peripheral tissues (Berridge, 
1993; Fasolato et al., 1991; Kasai and Petersen, 1994).  Evi- 
dence suggesting the presence in these tissues of calcium- 
operated channels differing from InsP3 receptors have been 
obtained studying the molecular mechanisms that regulate 
the concentration and diffusion of calcium in the cytosol 
(Pozzan et al.,  1994).  With the development of digital cal- 
cium imaging techniques, it has become clear that changes 
in intracellular calcium concentration take place as spacio- 
temporal events,  such as  calcium waves  and oscillations, 
regulating a variety of functions (i.e., fertilization of eggs, 
cellular mobility, and release of hormones and neurotrans- 
mitters) (Augustine and Neher, 1992; Brundage et al., 1991; 
Kasai and Augustine, 1990; Miyazaki, 1988; Smith and Au- 
gustine,  1988).  Such  waves and  oscillations  seem  to  be 
generated by the concerted action of more types of intracel- 
lular calcium release channels, probably localized in distinct 
regions of the cell (Kasai et al.,  1993; Thorn et al.,  1993). 
However, whether these cells expressed the same RyRs pres- 
ent in muscle cells has not yet been clarified nor it is clear 
if they express more than one of the three known RyR iso- 
forms. 
This  appears  to  be  true  also  for  smooth muscle  cells 
which,  although  provided  with  InsP3-operated  calcium 
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1994;  Zhang et al.,  1993).  Functional data have also indi- 
cated that RyRs prepared from aorta smooth muscle cells are 
similar to RyR1 and RyR2 (Hermann-Frank et al.,  1991). 
More  recently,  an  RyR has  been  partially  purified  and 
characterized from the visceral smooth muscle of the toad 
bufo marinus (Xu  et al.,  1994).  Expression of the RyR2 
mRNA  has  been  reported  in  aorta  smooth muscle cells 
(Moschella  and  Marks,  1993),  and  expression of RyR3 
mRNA  in  smooth muscle cells  has  also been  suggested 
(Hakamata et al., 1992).  Accordingly, we have found by in 
situ hybridization that in vas deferens and uterus, RyR3 is ex- 
pressed in correspondence of areas that are rich in smooth 
muscle cells. However, it should be noted that in tissues such 
as the stomach gut, aorta, etc., where RyR3 expression has 
been  associated  with  smooth muscle  cells,  RyR1 and/or 
RyR2 mRNA have also been detected (see Fig.  1 in this 
manuscript and Giannini et al., 1992; Moschella and Marks, 
1993). Therefore, it is possible that more than one RyR may 
be also expressed in smooth muscle cells, as it appears to be 
the case for neurons and germ cells. Analysis of RyRs in 
purified smooth muscle cells is currently being performed to 
answer this question. 
In skeletal muscle, both RyR1 and RyR3 are expressed. 
Expression of the RyR3 has also been studied in in vitro 
models of  muscular differentiation  such as the C2C12 and the 
BC3H1 myogenic cell lines. In these cells, we have found that 
increasing levels of RyR3 mRNA are associated with expres- 
sion of the  differentiated phenotype.  Detection  of RyR3 
along with RyR1 in mammalian skeletal muscle is in agree- 
ment with detection of caffeine responsiveness in muscle 
preparation from mice where the RYR1 gene had been func- 
tionally altered by homologous recombination techniques 
(Takeshima et al.,  1994).  This result apparently contrasts 
with the reported absence of caffeine response in cells ex- 
pressing RyR3 (Giannini et al.,  1992).  More recent data, 
however,  indicate that the lack of appreciable responses of 
caffeine could be caused by the low levels of RyR3 expressed 
in those cells, rather than revealing the distinctive property 
of the RyR3 isoform (Rossi, D., and V. Sorrentino, unpub- 
lished results). 
Since RyRs are known to be expressed in neurons and 
smooth muscle cells, it could be claimed that detection of 
RyRs in many tissues may be caused by the fraction of neu- 
ronal and smooth muscle cells present in these tissues. Sev- 
eral evidences argue against this possibility: (a) In situ hy- 
bridization analysis of RyRs in several tissues, including the 
stomach, gut, aorta, spleen, etc., did not always label areas 
enriched in smooth muscle cells. (b) The relative levels of 
RyRs expression vary from tissue to tissue in a way that does 
not correlate with the presence of neuronal and smooth mus- 
cle cells.  In the liver,  to our surprise,  we did not detect 
significant levels of RyRs mRNAs.  (c)  In the testis, both 
RyR1 and RyR3 mRNAs were distinctly expressed in germ 
cells. It is, therefore, more likely that RyRs expression in pe- 
ripheral tissues is not limited to neurons and muscle cells. 
This is also supported by detection of RyRs rnRNAs in sev- 
eral cell lines of different lineage, such as fibroblasts, epithe- 
lial, and hematopoietic cells, as reported in Fig. 8. 
What determines the choice of a given cell to express one 
RyR instead of another, or a specific combination of more 
than one isoform, is not clear. In at least a few cases, the em- 
bryological origin of the cells may dictate the preference for 
one RyR isoform instead of  others, as observed in pulmonary 
vessels (Lyons et al., 1990).  It is, however, more likely that 
the  regulatory  properties  of the  different  isoforms  may 
influence this decision (Ehrlich et al., 1994; Percival et al., 
1994). In this context, it is noteworthy to recall that expres- 
sion ofRyR  mRNAs, at least in vitro, seems to be influenced 
in part by TGF~. In HeLa ceils, for example, TGF~ induces 
the expression of the RyR1 mRNA and abolishes expression 
of RyR3 mRNA. These findings, together with other previ- 
ously reported data (Giannini et al., 1992),  suggest that the 
expression of the different isoforms may be  coordinately 
regulated, and that TGF/3 and other growth factors in general 
may have a modulatory role in determining quantitative and 
qualitative changes in RyRs expression in at least certain 
cells. Such changes may have influence on the generation of 
intracellular calcium  signals  (Berridge,  1993;  Kasai and 
Petersen,  1994). 
The low levels at which RyRs are expressed in many cells 
have been an obstacle to their localization outside skeletal 
and cardiac muscles and the brain. In this paper, we demon- 
strate that many cells express different isoforms of RyRs in 
addition to the InsP3 receptor isoforms (De Smedt et al., 
1994;  Ferris and Snyder,  1992;  Mikoshiba,  1993).  From 
such a complex pattern, it emerges that the calcium release 
channels, i.e.,  an important component of the machinery 
controlling intracellular calcium levels, may vary from cell 
to cell. The reason for such a finely tuned diversification will 
probably become clearer when we know more about the 
regulatory properties of the different RyR isoforms and their 
functional interaction with InsP3 receptors, and when more 
information on intraceUular localization of  all these channels 
becomes available.  The data presented here about the ex- 
pression of RyR genes, as well as our preliminary results at 
the protein level, suggest that the actual amounts of RyRs 
present in many cells are rather low.  However,  given the 
larger conductance of RyRs with respect to that of the InsP3 
receptors,  it may be expected that specific localization of 
even a few RyR channels to specific cellular microdomains 
may be effective in regulating the concentration of calcium 
in these intracellular districts. Clearly, much work remains 
to be done; however, the results reported here call for further 
investigation about RyRs to verify the extent of the contribu- 
tion of these channels to the regulation of intracellular cal- 
cium homeostasis. 
We thank all colleagues that have read and discussed this manuscript, as 
well as the reviewers for comments that helped improve the original draft. 
We thank D. Lazzaro and D. Bachiller for suggestions  on in situ hybridiza- 
tion and A. Charlesworth for technical assistance. 
This work was supported by grants from Telethon, AIRC, MURST-60%, 
and AIDS to V. Sorrentino. G. Giannini was supported by a fellowship from 
Istituto Pasteur Fondazione Cenci-Bolognetti. 
Received for publication  19 July  1994 and in revised form 3  November 
1994. 
References 
Aguanno,  S.,  M.  Bouch~,  S.  Adamo,  and  M.  Molinaro.  1990.  12-O- 
tetradecanoylphorbol-13-acetate-induced differentiation  of a  human rhab- 
domysarcoma cell line. Cancer Res.  50:3377-3382. 
Airey, J. A., M. D. Baring, and J. L. Sutko.  1991. Ryanodine receptor protein 
is expressed during differentiation  in  the muscle cell  lines BC3HI  and 
C2C12. Dev. Biol.  148:365-374. 
The Journal of Cell  Biology, Volume 128,  1995  902 Augustine, G. J., and E. Neher.  1992. Calcium requirements for secretion in 
bovine chromaffin cells. J.  Physiol.  450:247-271. 
Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. 
Smith, and K. Strohl.  1993. Current Protocols in Molecular Biology. John 
Wiley & Sons,  Inc., New York. 
Berridge,  M. J.  1993. lnositol trisphosphate  and calcium signalling.  Nature 
(Lond. ).  361:315-325. 
Brundage, R. A., K. E. Fogarty,  R. A. Tuft, and F. S. Fay.  1991. Calcium 
gradients  underlying  polarization  and chemotaxis  of eosinophils.  Science 
(Wash.  DC). 254:703-706. 
Coccia,  E.  M., C.  Cieala,  A. Charlesworth,  C.  Ciccarelli,  G. B.  Rossi,  L. 
Philipson, and V. Sorrentino.  1992. Regulation and expression of a growth 
arrest-specific gene (gas5) during growth, differentiation, and development. 
Mol.  Cell Biol.  12:3514-3521. 
Coronado, R., J. Morrissette, M. Sukhareva, and D. M. Vaugham. 1994. Struc- 
ture  and  function  of ryanodine  receptors.  Am.  J.  Physiol.  266:C1485- 
C1504. 
De Smedt, H., L. Missiaen, J. B. Parys, M. D. Boounan, L. Mertens, L. V. D. 
Bosch, and R. Casteels.  1994. Determination of relative amounts of inositol 
trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. 
J.  Biol.  Chem.  269:21691-21698. 
Dollr,  P., and D. Duboule.  1989. Two gene members of the murine HOX-5 
complex show regional and ceU-type specific expression in the developing 
limbs and gonads. EMBO (Eur. Mol.  Biol.  Organ.) J.  8:1507-1515. 
Ehrlich, B. E., E. Kaftan, S. Bezprovannaya, and I. Bezprozvanny. 1994. The 
pharmacology  of intracellular  Ca2÷-release channels.  Trends  Pharmacol. 
Sci.  15:145-149. 
Fasolato, C., M. Zottini, E. Clementi, D. Zacchetti, J. Meldolesi, and T. Poz- 
zan.  1991. IntraceUular Ca  2÷ pools  in  PCI2  cells.  J.  BioL  Chem.  266: 
20159-20167. 
Ferris, C.  D., and S. H. Snyder.  1992. Inositol  1,4,5-trisphosphate-activated 
calcium channels. Annu.  Rev.  Physiol.  54:469-488. 
Furuichi, T., C. Shiota, and K. Mikoshiba. 1990. Distribution ofinositol 1,4,5- 
trisphosphate receptor mRNA in mouse tissues. FEBS (Fed. Eur. Biochem. 
Soc.).  267:85-88. 
Galione, A.  1993. Cyclic ADP-ribose: a new way to control calcium. Science 
(Wash.  DC). 259:3258-326. 
Galione,  A.,  A.  McDougall,  W.  B.  Busa,  N.  Willmot,  I.  Gillot,  and  M. 
Whitaker. 1993. Redundant mechanisms of calcium-induced calcium release 
underlying calcium waves during  fertilization of sea urchin eggs. Science 
(Wash.  DC). 261:348-352. 
Giannini, G., E. Clementi, R. Ceci, G. Marziali, and V. Sorrentino.  1992. Ex- 
pression of a ryanodine receptor-Ca 2+ channel that is regulated by TGF-fl. 
Science (Wash.  DC). 257:91-94. 
Gorza, L., S. Vettore, P. Volpe, V. Sorrentino, J.-L.  Samuel, M. Anger, and 
A. M. lompre.  1995. Cardiac myocytes differ in mRNA composition for sar- 
coplasmic reticulum calcium channels and calcium pumps. Ann.  NYAcad. 
Sci.  In press. 
Hakamata, Y., J. Nakai, H. Takeshima, and K. Imoto. 1992. Primary structure 
and distribution of a novel ryanodine receptor/calcium release channel from 
rabbit brain.  FEBS (Fed. Eur.  Biochem.  Soc.) 312:229-235. 
Hermann-Frank, A., E. Darling, and G. Meissner. 1991. Functional character- 
ization of the Ca2+-gated Ca  2+ release channel of vascular smooth muscle 
sarcoplasmic reticulum.  Pflagers  Arch. 418:353-359. 
Howard, M., J. C. Grimaldi, J. F. Bazan, F. E. Lurid, L. Santos-Agrumedo, 
R. M. E. Parkhouse,  T. F. Walseth,  and H. C. Lee.  1993. Formation and 
hydrolysis of cyclic  ADP-ribose  catalyzed by lymphocyte antigen CD38. 
Science (Wash.  DC). 262:1056-1059. 
Hynes, N. E., D. Taverna, 1. M. Harwerth,  F. Ciardello,  D. S. Salomon, T. 
Yamamoto, and B. Groner.  1990. Epidermal growth factor receptor, but not 
c-erb B-2, activation prevents lactogenic hormone induction of the E-casein 
gene in mouse mammary epithelial cells. Mol.  Cell Biol.  10:4027--4034. 
Kasai,  H.,  and  G.  J.  Augustine.  1990. Cytosolic  Ca  ~+ gradients  triggering 
unidirectional fluid secretion from exocrine pancreas. Nature (Lond.).  348: 
735-738. 
Kasai, H., Y. X. Li, and Y. Miyashita.  1993. Subcellular distribution of Ca  2÷ 
release channels underlying  Ca  2÷ waves and oscillations  in exocrine pan- 
creas.  Cell.  74:669-677. 
Kasai, H., and O. H. Petersen.  1994. Spatial dynamics of second messengers: 
IP3 and cAMP as long-range and associative messengers.  Trends Neurosci. 
17:95-101. 
Kuwajiima, G., A. Futatsugi,  M. Niinobe, S.  Nakanishi, and K. Mikoshiba. 
1992. Two types of ryanodine receptors in mouse brain: skeletal muscle type 
exclusively  in purkinje cells and cardiac  muscle type in various neurons. 
Neuron. 9:1133-1142. 
Lee,  H. C., R. Aarhus,  and T. F. Warlseth.  1993. Calcium mobilization by 
dual receptors during fertilization of sea urchin eggs. Science (Wash. DC). 
261:352-355. 
Lesh,  R.  E., A. R.  Marks,  A. V. Somiyo, S. Fleischer,  and A. P.  Somlyo. 
1993.  Anti-ryanodne  receptor  antibody  binding  sites in vascular and en- 
docardia endothelium.  Circ. Res.  72:481-488. 
Lyons G. E., S. Schiaffino, D. Sassoon, P. Barton, and M. Buckingham. 1990. 
Development regulation of myosin gene expression in mouse cardiac muscle. 
J.  Cell Biol.  111:2427-2436. 
Marziali, G., D. Lazzaro, and V. Sorrentino.  1993. Binding germ cells to mu- 
tant SI  d sertoli cells is defective and is rescued by expression of the trans- 
membrane form of the c-kit ligand. Dee.  Biol.  157:182-190. 
Mattei,  M. G., G.  Giannini, F. Moscatelli,  and V.  Sorrentino.  1994. Chro- 
mosomal localization of  murine ryanodine receptor genes RYR 1, RYR2, and 
RYR3 by in situ hybridization.  Genomics.  22:202-204. 
McPherson,  S. M., P. S. McPberson,  L. Mathews, K. P. Campbell, and F. J. 
Longo. 1992. Cortical localization of a calcium release channel in sea urchin 
eggs. J.  Cell Biol.  117:1111-1121. 
McPherson,  P. S., and K. P. Campbell.  1993a. Characterization of the major 
brain form of the ryanodine receptor/Ca 2+ release channel. J. Biol.  Chem. 
268:19785-19790. 
McPherson,  P. S., and K. P. Campbell.  1993b. The ryanodine receptor/Ca ~+ 
release channel. Jr. Biol.  Chem.  268:13765-13768. 
Mikoshiba, K. 1993. Inositol 1,4,5-trisphosphate receptor. Trends Pharmacol. 
Sci.  14;86-89. 
Miyazaki, S. 1988. Fertilization potential and calcium transients in mammalian 
eggs. Dee.  Growth Differ.  30:603-610. 
Morrone, G., R. Cortese, and V. Sorrentino.  1989. Post-transcriptional control 
of negative acute phase genes by transforming growth factor beta.  EMBO 
(Eur.  Mol.  Biol.  Organ.)J.  8:3767-3771. 
Moscbella, M. C., and A. R. Marks.  1993. Inositol 1,4,5-trisphosphate recep- 
tor expression in cardiac myocytes. J.  Cell Biol.  120:1137-1146. 
Nakagawa, T., H. Okano, T. Furoichi, J. Aruga, and K. Mikoshiba. 1991. The 
subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in 
a tissue-specific and developmentally specific manner. Proc. Natl. Acad. Sci. 
USA.  88:6244-6248. 
Nakai, J., T. Imagawa, Y. Hakamata, M. Shigekawa, H. Takeshima,  and S. 
Numa. 1990. Primary structure and functional expression from cDNA of the 
cardiac ryanodine receptor/calcium  release channel FEBS (Fed. Fur. Bio- 
chem.  Soc.) 271:169-177. 
Otsu, K., H. F. Willard,  V. K. Khanna, F. Zorzato,  N. M. Green,and D. H. 
MacLennan.  1990. Molecular cloning of cDNA encoding the Ca  2+ release 
channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticu- 
lure. J. Biol.  Chem.  265:13472-13483. 
Percival, A. L., A. J. Williams, J. L. Kenyon, M. M. Grinsell, J. A. Airey, 
and J.  L.  Sutko.  1994. Chicken  skeletal muscle  ryanodine  receptor  iso- 
forms/ion channel properties.  Biophys.  J.  67:1834-1844. 
Pozzan, T., R. Rizzuto., P. Volpe, and J. Meldolesi.  1994. Molecular and cel- 
lular physiology of intracellular calcium stores. Physiol.  Rev.  74:595-637. 
Ross, C. A., S. K, Danoff, M. J. Schell, S. H. Snyder, and A. UIIrich. 1992. 
Three additional inositol  1,4,5-trisphosphate  receptors:  molecular cloning 
and differential localization in brain and peripheral tissues. Proc. Natl. Acad. 
Sci.  USA.  89:4265--4269. 
Schmid, A., M. Dehlinger-Kremer, I. Schulz, and H. G-rgelein. 1990. Voltage- 
dependent lnsP3-insensitive calcium channels in membranes of pancreatic 
endoplasmic reticulum vesicles. Nature (Lond.).  346:374-376. 
Sharp, A. H., P. S. McPherson, T. M. Dawson, C. Aoki, K. P. Campbell, and 
S. H. Snyder. 1993. Differential immunohistocbemical localization ofinosi- 
tol 1,4,5-trisphosphate- and ryanodine-sensitive Ca  2+ release channels in rat 
brain. J. Neurosci.  13:3051-3063. 
Shoshan-Barmatz,  V.,  T.  Pressley,  S.  Higham,  and  N.  Kraus-Friedmann. 
1991. Characterization  of high-affinity ryanodine-binding  sites of rat liver 
endoplasmic reticulum: differences between liver and skeletal muscle. Bio- 
chem.  J.  276:41-46. 
Smith, D. B., and K. S. Johnson.  1988. Single step purification of polypeptides 
expressed in E. coli as fusions with glutathione-S-transferase. Gene (Amst.). 
67:31-40. 
Smith, S. J., and G. J. Augustine. 1988. Calcium ions, active zones and synap- 
tic transmitter  release.  Trends Neurosci.  11:458-464. 
Sorrentino, V., G. Giannini, P. Malzac, and M. G. Mattei.  1993. Localization 
of a novel ryanodine receptor gene (RYR3) to human chromosome 15q14- 
q15 by in situ hybridization.  Genomincs.  18:163-165. 
Sorrentino,  V., and P. Volpe.  1993. Ryanodine receptors:  bow many, where 
and why? Trends Pharmacol.  Sci.  14:98-105. 
Takasawa,  S., K. Nata, H. Yonekura,  and H. Okamoto.  1993. Cyclic ADP- 
ribose  in insulin secretion  from pancreatic  /3 cells.  Science (Wash.  DC). 
259:370-373. 
Takeshima,  H., M.  lino,  H. Takekura,  M.  Nishi,  J.  Kuno,  O. Minowa,  H. 
Takano, and T. Noda. 1994. Excitation-contraction uncoupling and muscu- 
lar  degeneration  in  mice  lacking  functional  skeletal  muscle  ryanodine- 
receptor gene. Nature (Lond.).  369:556-559. 
Takeshima,  H.,  S.  Nishimura,  T.  Matsumoto,  H.  Ishida,  K.  Kangawa,  N. 
Minamino,  H. Matsuo,  M.  Ueda, M. Hanaoka,  T.  Hirose,  and S.  Numa. 
1989. Primary structure and expression from complementary DNA of skele- 
tal muscle ryanodine receptor.  Nature (Lond.).  339:439--445. 
Thorn, P., A. M. Lawrie, P. M. Smith, D. V. Gallacher, and O. H. Petersen. 
1993. Local and global cytosolic Ca  2÷ oscillations in exocrine cells evoked 
by agonists and inositol trisphosphate.  Cell.  74:661-668. 
Verma, A., D. J. Hirsch,  and S. H. Snyder.  1992. Calcium pools mobilized 
by calcium or inositol 1,4,5-trisphosphate are differentially localized in rat 
heart and brain. MoL  Biol.  Cell.  3:621-631. 
Verma, A., C. A. Ross, D. Verma, S. Supattapone, and S. H. Snyder.  1990. 
Rat brain endoplasmic reticulum calcium pools are anatomically and func- 
tionally segregated.  Cell Regul.  1:781-790. 
Walton,  P.  D., J.  A. Arey,  J.  L. Sutko, C. F.  Beck, G. A. Mignery,  T. C. 
Giannini et al.  Tissue Expression of Ryanodine Receptors  903 Sudhof, T. J. Deerinck, and M. H. Ellisman.  1991. Ryanodine and inositol 
trisphosphate receptors coexist in avian cerbellar purkinje neurons. J.  Cell 
Biol.  113:1145-1157. 
Wibo, M., and T. Godfralnd. 1994. Comparative localization of inositol 1,4,5- 
trisphosphate and ryanodine receptors in intestinal smooth muscle: an analyti- 
cal subfractionation study. Biochem.  J.  297:415--423. 
Xu, L., F. A. Lai, A. Cohn, E. Etter, A. Guerriero, F. S. Fay, and G. Meiss- 
ner.  1994. Evidence  for  a  Ca2*-gated ryanodine-sensitive  Ca  2÷  release 
channel  in  visceral  smooth  muscle.  Proc.  Natl.  Acad.  Sci.  USA.  91: 
3294-3298. 
Zhang, Z., C. Kwan, and E. D. Daniel. 1993. Subcellular-membrane character- 
ization  of [3H] ryanodine-binding  sites  in  smooth  muscle.  Biochem.  J. 
290:259-266. 
Zorzato F., J. Fujii, K. Otsu, M. Phillips, N. M. Green, F. A. Lai, G. Meiss- 
her, and D. H. MacLarman. 1990. Molecular cloning of cDNA encoding hu- 
man and rabbit forms of the Ca  2+ release channel (ryanodine receptor) of 
skeletal muscle sarcoplasmic reticulum. J.  Biol.  Chem.  265:2244-2256. 
The Journal of Cell Biology, Volume  128, 1995  904 